http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009133470-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c7401c5a4678ae7107cb19df7740c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ea80348f31666e8b0dbd64a76e3a774
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2009-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b7350fe0c9f77d3e10a1b29802ebe0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aa9995e5179279cdb61db5252c4e2cd
publicationDate 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009133470-A3
titleOfInvention Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level
abstract Use of dronedarone or one of its pharmaceutically acceptable salts for preparing a medicament for the treatment of patients with arrhythmia, said patients having an increase of creatinine level due to dronedarone administration, said creatinine level increasing following dronedarone treatment initiation, said creatinine level increase reaching a plateau and being used as a new baseline, said creatinine level increase being reversible after dronedarone discontinuation.
priorityDate 2008-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007140989-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004339218-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003229007-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0247660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0215891-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0027380-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4868179-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0796617-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226483798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129941685

Total number of triples: 36.